Drug profile · INN
panitumumab
VECTIBIX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
panitumumab (VECTIBIX) is an FDA-listed pharmaceutical active ingredient. Associated with Amgen. Route of administration: iv (infusion). Current US regulatory status: approved.
Key facts
INN panitumumab
Brand VECTIBIX
Route IV (INFUSION)
Formulation INJECTABLE
ATC code L01XC08
Originator Amgen
Frequently asked questions
What is panitumumab?
panitumumab (VECTIBIX) is an FDA-listed pharmaceutical active ingredient. Associated with Amgen. Route of administration: iv (infusion). Current US regulatory status: approved.
What is the brand name for panitumumab?
VECTIBIX is a marketed brand name for panitumumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of panitumumab?
panitumumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.